Clinical characterization of Staphylococcus schleiferi infections and identification of risk factors for acquisition of oxacillin-resistant strains in dogs: 225 cases (2003-2009)

Journal of the American Veterinary Medical Association

Volumn 239, Issue 12, 2011, Pages 1566-1573

  Cain, Christine L ^a,c   Morris, Daniel O ^a   Rankin, Shelley C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82755190954     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.239.12.1566     Document Type: Article

References (40)

1. Freney J, Brun Y, Bes M, et al. Staphylococcus lugdunesis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical samples. Int J Syst Bacteriol 1988;38:168-172.
2. Igimi S, Takahashi E, Mitsuoka T. Staphylococcus schleiferi subsp. coagulans subsp. nov., isolated from the external auditory meatus of dogs with external ear otitis. Int J Syst Bacteriol 1990;40:409-411.
3. Peacock SJ, Lina G, Etienne J, et al. Staphylococcus schleiferi subsp. schleiferi expresses a fibronectin-binding protein. Infect Immun 1999;67:4272-4275.
4. Calvo J, Hernandez JL, Farinas, MC, et al. Osteomyelitis caused by Staphylococcus schleiferi and evidence of misidentification of this Staphylocccus species by an automated bacterial identification system. J Clin Microbiol 2000;38:3887-3889.
5. Da Costa A, Lelievre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections. Circulation 1998;97:1791-1795.
6. Hernandez JL, Calvo J, Sota R, et al. Clinical and microbiological characteristics of 28 patients with Staphylococcus schleiferi infection. Eur J Clin Microbiol Infect Dis 2001;20:153-158.
7. Kluytmans J, Berg H, Steegh P, et al. Outbreak of Staphylococcus schleiferi wound infections: strain characterization by randomly amplified polymorphic DNA analysis, PCR ribotyping, conventional ribotyping, and pulsed-field gel electrophoresis. J Clin Microbiol 1998;36:2214-2219.
8. Leung MJ, Nuttall N, Mazur M, et al. Case of Staphylococcus schleiferi endocarditis and a simple scheme to identify clumping-factor positive staphylococci. J Clin Microbiol 1999;37:3353-3356.
9. Vandenesch F, Lebeau C, Bes M, et al. Clotting activity in Staphylococcus schleiferi subspecies from human patients. J Clin Microbiol 1994;32:388-392.
10. Kumar D, Cawley JJ, Irizarry-Alvarado JM, et al. Case of Staphylococcus schleiferi subspecies coagulans endocarditis and metastatic infection in an immune compromised host. Transpl Infect Dis 2007;9:336-338.
11. Piette A, Verschraegen G. Role of coagulase-negative staphylococci in human disease. Vet Microbiol 2009;134:45-54.
12. Koksal F, Yasar H, Samasati M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res 2009;164:404-410.
13. Frank LA, Kania SA, Hnilica KA, et al. Isolation of Staphylococcus schleiferi from dogs with pyoderma. J Am Vet Med Assoc 2003;222:451-454.
14. May ER, Hnilica KA, Frank LA, et al. Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both. J Am Vet Med Assoc 2005;227:928-931.
15. Morris DO, Rook KA, Shofer FS, et al. Screening of Staphylococcus aureus, Staphyococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). Vet Dermatol 2006;17:332-337.
16. Yamashita K, Shimizu A, Kawano J, et al. Isolation and characterization of staphylococci from external auditory meatus of dogs with or without otitis externa with special reference to Staphylococcus schleiferi subsp. coagulans isolates. J Vet Med Sci 2005;67:263-268.
17. Cain CL, Morris DO, O'Shea K, et al. Genotypic relatedness and phenotypic characterization of Staphylococcus schleiferi subspecies in clinical samples from dogs. Am J Vet Res 2011;72:96-102.
18. Jones RD, Kania SA, Rohrbach BW, et al. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). J Am Vet Med Assoc 2007;230:221-227.
19. Kania SA, Williamson NL, Frank LA, et al. Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. Am J Vet Res 2004;65:1265-1268.
20. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781-791.
21. Guardabassi L, Loeber ME, Jacobson A. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet Microbiol 2003;98:23-27.
22. Iorio NL, Ferreira RB, Schuenck RP, et al. Simplified and reliable scheme for species-level identification of Staphylococcus clinical isolates. J Clin Microbiol 2007;45:2564-2569.
23. Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: informational supplement. Document M31-A3. Wayne, Pa: CLSI, 2008.
24. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. Wayne, Pa: CLSI, 2006.
25. Sasaki T, Kikuchi K, Yoshikazu T, et al. Reclassification of phenotypically identified Staphylococcus intermedius strains. J Clin Microbiol 2007;45:2770-2778.
26. Bes M, Guerin-Faublee V, Freney J, et al. Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma. Vet Rec 2002;150:487-488.
27. Scott DW, Miller WH, Griffin CE. Bacterial skin diseases. In: Scott DW, Miller WH, Griffin CE, eds. Muller and Kirk's small animal dermatology. 6th ed. Philadelphia: WB Saunders Co, 2001;277;581, 618.
28. Mason IS, Mason KV, Lloyd DH. A review of canine skin with respect to the commensals Staphylococcus intermedius, Demodex canis and Malassezia pachydermatis. Vet Dermatol 1996;7:119-132.
29. Griffeth GC, Morris DO, Abraham JL, et al. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol 2008;19:142-149.
30. Pinchbeck LR, Cole LK, Hillier A, et al. Genotypic relatedness of staphylococci strains isolated from pustules and carriage sites in dogs with superficial bacterial folliculitis. Am J Vet Res 2006;67:1337-1346.
31. Fitzgerald JR. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and emergence of methicillin resistance. Vet Dermatol 2009;20:490-495.
32. Chaves F, Garcia-Martinez J, de Miguel S, et al. Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain. Infect Control Hosp Epidemiol 2005;26:150-156.
33. Hseuh PR, Chen WH, Teng LJ, et al. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycinresistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activity of newer antimicrobial agents. Int J Antimicrob Agents 2005;26:43-49.
34. Crowcroft NS, Ronveaux O, Monnet DL, et al. Methicillinresistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999;20:31-36.
35. Faires MC, Traverse M, Tater KC, et al. Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs. Emerg Infect Dis 2010;16:69-75.
36. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998;19:552-559.
37. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002;49:999-1005.
38. Weber SG, Gold HS, Hooper DC, et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003;9:1415-1422.
39. Bisognano C, Vaudaux PE, Rohner P, et al. Induction of fibronectin- binding proteins and increased adhesion of quinoloneresistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agens Chemother 2000;44:1428-1437.
40. Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997;24(suppl 1):S67-S73.